July 2017 ENCALS statement on edaravone

• Autor(a) principal: Al-Chalabi, Ammar
• Data de Publicação: 2017
• Outros Autores: Andersen, Peter M., Chandran, Siddharthan, Chio, Adriano, Corcia, Philippe, Couratier, Philippe, Danielsson, Olof, Carvalho, Mamede, Desnuelle, Claude, Grehl, Torsten, Grosskreutz, Julian, Holmøy, Trygve, Ingre, Caroline, Karlsborg, Merete, Kleveland, Grethe, Christoph Koch, Jan, Koritnik, Blaz, KuzmaKozakiewicz, Magdalena, Laaksovirta, Hannu, Ludolph, Albert, McDermott, Christopher, Meyer, Thomas, Mitre Ropero, Bernardo, Mora Pardina, Jesus, Nygren, Ingela, Petri, Susanne, Povedano Panades, Mónica, Salachas, Francois, Shaw, Pamela, Silani, Vincenzo, Staaf, Gert, Svenstrup, Kirsten, Talbot, Kevin, Tysnes, Ole-Bjørn, Van Damme, Philip, van der Kooi, Anneke, Weber, Markus, Weydt, Patrick, Wolf, Joachim, Hardiman, Orla, van den Berg, Leonard H.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10451/51497

© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.